Literature DB >> 27312583

Estimating and mapping the incidence of giardiasis in Colombia, 2009-2013.

Alfonso J Rodríguez-Morales1, Santiago Granados-Álvarez2, Harold Escudero-Quintero2, Felipe Vera-Polania2, Alvaro Mondragon-Cardona2, Fredi Alexander Díaz-Quijano3, Leonardo Sosa-Valencia4, Carlos O Lozada-Riascos5, Angel A Escobedo6, Olivia Liseth7, Ubydul Haque8.   

Abstract

BACKGROUND: Giardiasis is one of the most common intestinal infections in the world. There have been no national studies on the morbidity of giardiasis in Colombia. In this study, incidence rates of giardiasis were estimated for the years 2009-2013.
METHODS: An observational, retrospective study of the giardiasis incidence in Colombia, 2009-2013, was performed using data extracted from the personal health records system (Registro Individual de Prestación de Servicios, RIPS). Official population estimates from the National Department of Statistics (DANE) were used for the estimation of crude and adjusted incidence rates (cases/100 000 population).
RESULTS: During the period studied, 15 851 cases were reported (median 3233/year; 5-year cumulated crude national rate of 33.97 cases/100 000 population). Of these, 50.3% were female; 58.4% were <10 years old and 14.8% were 10-19 years old. By region, 17.7% were from Bogotá (10.07 cases/100 000 population, 2009), 10.9% from Antioquia (9.42, 2009), 8.6% from Atlántico (15.67, 2009), and 6.5% from Risaralda (33.38, 2009). Cases were reported in all departments (even insular areas).
CONCLUSIONS: As giardiasis is neglected in many countries, surveillance is not regularly undertaken. Despite its limitations, this study is the first attempt to provide estimates of national giardiasis incidence with consistent findings regarding affected age groups and geographical distribution.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Colombia; Giardiasis; Infectious diseases epidemiology; Parasitic; Protozoan

Mesh:

Year:  2016        PMID: 27312583     DOI: 10.1016/j.ijid.2016.06.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009-2013, using geographical information systems: Implications for public health and travel medicine.

Authors:  Alfonso J Rodríguez-Morales; María Camila Yepes-Echeverri; Wilmer F Acevedo-Mendoza; Hamilton A Marín-Rincón; Carlos Culquichicón; Esteban Parra-Valencia; Jaime A Cardona-Ospina; Ana Flisser
Journal:  Travel Med Infect Dis       Date:  2017-12-27       Impact factor: 6.211

2.  Is Legionellosis Present and Important in Colombia? An Analyses of Cases from 2009 to 2013.

Authors:  Andrés Mauricio Patiño-Barbosa; Andrés Felipe Gil-Restrepo; Valentina Restrepo-Montoya; Wilmer E Villamil-Gomez; Jaime A Cardona-Ospina; Alfonso J Rodriguez-Morales
Journal:  Cureus       Date:  2017-03-28

3.  Molecular Epidemiology of Giardia, Blastocystis and Cryptosporidium among Indigenous Children from the Colombian Amazon Basin.

Authors:  Angie Sánchez; Marina Munoz; Natalia Gómez; Juan Tabares; Laura Segura; Ángela Salazar; Cristian Restrepo; Miguel Ruíz; Patricia Reyes; Yuchen Qian; Lihua Xiao; Myriam C López; Juan D Ramírez
Journal:  Front Microbiol       Date:  2017-02-21       Impact factor: 5.640

4.  Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries.

Authors:  Roberto Rodríguez-Rivas; Ana Flisser; Luiz Fernando Norcia; Pedro Tadao Hamamoto Filho; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales; Arturo Carpio; Matthew L Romo; Agnès Fleury
Journal:  PLoS Negl Trop Dis       Date:  2022-08-29

5.  Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.

Authors:  Juan-Sebastian Franco; David Vizcaya
Journal:  Pharmacol Res Perspect       Date:  2020-10

6.  Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia.

Authors:  Gabriel Carrasquilla; Alexandra Porras-Ramírez; Sandra Martinez; Rodrigo DeAntonio; Raghavendra Devadiga; Carla Talarico; Diana C Caceres; Maria M Castrejon; Patricia Juliao
Journal:  Hum Vaccin Immunother       Date:  2020-09-23       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.